BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.
Alexandra FrazaoLouise RethackerGéraldine JeudyMarina ColomboEric PasmantMarie-Françoise AvrilAntoine ToubertHelene Moins-TeisserencMarie RoelensSophie DalacEve MaubecAnne CaignardPublished in: Journal for immunotherapy of cancer (2021)
These results support strategies combining targeted therapies and NK-based immunotherapies.